India’s Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck’s diabetes drugs Januvia and Janumet, according to a court document released on Friday. The court has, however, allowed Glenmark to continue to sell existing inventory, according to the document posted on the Supreme Court’s website after a hearing. The […]

SAN FRANCISCO–(BUSINESS WIRE)–The California Supreme Court today resoundingly endorsed consumers’ right to challenge pharmaceutical pay-for-delay settlements under California competition law. Reversing a grant of summary judgment to Bayer and Barr, whose $398.1 million deal blocked access to affordable generic versions of the widely prescribed antibiotic Cipro for nearly seven years, the Court held that “[p]arties […]

A logo of GlaxoSmithKline Pharmaceuticals Ltd company is pictured outside its headquarters in Mumbai December 16, 2013. Reuters/Danish Siddiqui (Reuters) – After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics – but not just yet. Chief Executive Andrew Witty said on […]

(Reuters) – The U.S. Supreme Court on Monday brought to an end Bristol-Myers Squibb Co’s attempt to revive patent protection for its Baraclude treatment for hepatitis B. The high court declined to hear Bristol-Myers’ challenge to an appeals court ruling in favor of generic rival Teva Pharmaceutical Industries Ltd, which had successfully challenged the patent. […]